This website uses its own and third-party cookies in order to improve the browsing experience. If you continue browsing you will be accepting expressly the use of these cookies. You can get more information on our Cookies policy page.



OSASEN is working to find solutions to the Covid-19 by applying its technology to the development of a new serological test to detect antibodies against SARS-CoV-2.

The degree of specialization that OSASEN is forging around the research and development of Point of Care (PoC) devices and systems based on biosensors with application to in vitro diagnosis, includes the possibility of developing rapid tests that facilitate the diagnosis and monitoring of the disease. 

In this sense, OSASEN is working on the application of its technology to obtain a new serological test that allows the rapid, simple and accurate detection of antibodies against SARS-CoV-2 in people who are or have been infected by the virus that causes Covid-19. 

Given the global relevance of the current crisis caused by Covid-19, OSASEN will intensify its efforts and resources to focus on this technological development, which can be used for the diagnosis of patients with negative PCR and to carry out epidemiological studies to better understand the incidence and spread of the virus.